Accelmed Partners II LP
Private equity fundMiami, United States (Accelmed manager office; fund vehicle distinct)See on the mapaccelmed.com
Health specialist
Accelmed Partners II LP is a private equity fund focused on control and growth investments in commercial-stage healthcare technology companies.
- 3
- Portfolio companies on reccy
- 2
- Hiring now
- 27
- Open roles in the portfolio
- Oct 2021
- Latest portfolio round
Hiring now in the portfolio27
Apply on each company's site- Posted 1d ago
Associate Therapy Consultant - Fresno
NeuroPace · Fresno, California
- Posted 1d ago
Director/Senior Director, Science
Click Therapeutics · New York, NY or Remote
- Posted 2d ago
Associate Therapy Consultant - Birmingham
NeuroPace · Birmingham, AL
- Posted 3d ago
Associate Therapy Consultant - San Francisco Bay Area
NeuroPace · San Francisco, CA
- Posted 4d ago
Associate Therapy Consultant - Fort Worth
NeuroPace · Fort Worth, Texas
- Posted 5d ago
Associate Therapy Consultant - Charleston
NeuroPace · Charleston, South Carolina
- Posted 9d ago
Therapy Consultant - Detroit
NeuroPace · Detroit, Michigan
- Posted 9d ago
Associate Therapy Consultant - Indianapolis
NeuroPace · Indianapolis, IN
Portfolio on reccy3
From company funding records- Venture Round · $33M · Aug 202021 roles
NeuroPace
Mountain View, CA · Led a round · Venture Round · $33M · Aug 2020
- Series B · $52M · Oct 20216 roles
Click Therapeutics
New York, NY · Led a round · Series B · $52M · Oct 2021
- Seed · $2.5M · Nov 2015None
Sonivie
Rosh Ha'ayin, Israel · Led a round · Seed · $2.5M · Nov 2015
Their companies, round by round
From company funding records- NeuroPaceMountain View, CA
EEG and neural monitoring · Neuromodulation
- Aug 2025Grant · $6.8M
- Jun 2025Post-IPO Debt · $75M
- Feb 2025Post-IPO Equity · $74.8M
- Jun 2021Grant · $9.3M
- Aug 2020Convertible Note · $34M
- Aug 2020Venture Round · $33MLed
- Click TherapeuticsNew York, NY
Digital therapeutics
- Apr 2026Series D · $50M
- Mar 2025Series C
- Oct 2021Series B · $52MLed
- Jul 2018Financing · $17M
- UndatedVenture Round
- UndatedDebt Financing
- SonivieRosh Ha'ayin, Israel
- Jan 2023Series C · $60M
- Oct 2021Venture Round · $150K
- Nov 2015Seed · $2.5MLed
Rounds marked Led list Accelmed Partners II LP as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Oct 2021
Click Therapeutics · Series B $52MLead
With H.I.G. BioHealth Partners
- Aug 2020
NeuroPace · Venture Round $33MLead
With Accelmed Partners, KCK, KCK Group, Johnson & Johnson Development Corporation, Revelation Partners, Soleus Capital, OrbiMed Advisors
- Nov 2015
Sonivie · Seed $2.5MLead
Portfolio in the news
From the Cortex · last 12 months- Oct 2026